Project Grant HT94252410141
Award Date 2/15/24
Completion Date 2/14/26
Dollars Obligated $313K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bethesda, MD 20814, USA
Similar Awards
- The Defense Health Agency awarded a $856,523 Project Grant to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on neurovascular and cognitive recovery from the spectrum of traumatic brain injuries through high-low therapy,...
- The U.S. Defense Health Agency awarded a $4,626,921 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period of August 1, 2025 to July 31, 2028, will fund research to elucidate the role of the neurovascular unit and related structural and functional neurological sequelae after exposure to repeated blast. This research aims to transform...
- The U.S. Defense Health Agency awarded a $749,822 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "Beyond Repair: Transformative Multistaged Treatment for Composite Tissue Injuries," will support advanced biomedical research to develop innovative medical solutions that address critical health challenges relevant to military personnel. The grant...
- The Defense Health Agency awarded a $488,086 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS TREATMENTS," is intended to support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. The performance period...
- The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. was awarded a $2,727,382 cooperative agreement from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The cooperative agreement will support research into blood-based biomarkers of traumatic brain injury and related vascular dementia from September 1, 2022 to August 31, 2026. Through this funding, the Foundation will investigate...
- The Department of Defense's Defense Health Agency awarded a $1,297,813 Cooperative Agreement to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This award, with a performance period from September 1, 2023 to August 31, 2027, aims to enhance functional restoration and accelerate return to duty following lower extremity autologous free-flap harvest procedures. As a global non-profit...
- This federal Project Grant award, valued at $319,151.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on a novel miR-155 therapy for the treatment of peripheral neuropathy. The project aims to develop new treatments, diagnostic tools, and clinical practice guidelines to improve the health and...
- The Defense Health Agency awarded a $783,023 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "A PRECISION-MEDICINE APPROACH TO TARGETING ACQUIRED THERAPEUTIC RESISTANCE IN RTK-MUTATED NSCLC" over a 3-year period from June 1, 2025 to May 31, 2028. The Military Medical Research and Development program supports advanced...
- The U.S. Department of Defense's Defense Health Agency awarded a $2,385,311 Project Grant (CFDA 12.420 - Military Medical Research and Development) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant will fund a 4-year study to evaluate the efficacy of a criteria-based clinical pathway for rehabilitation of shoulder injuries. The project involves technical expertise from sub-awardees the University of Southern California and The Geneva Foundation. Key...
- The U.S. Defense Health Agency (DHA) awarded a $505,228 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant, awarded on March 1, 2025, will support a 2-year research project investigating joint-level pathomechanics and methods to preserve knee joint health following lower limb loss, using simulated ambulation. The project aims to advance understanding and develop...